Peter Lebowitz
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Dr. Peter F.
Lebowitz is an Independent Director at Bridgebio Oncology Therapeutics, Inc., an Independent Director at Bridgebio Oncology Therapeutics, Inc. /New/, a Chief Executive & Medical Officer, Director at Third Arc Bio, Inc. and a Head-Oncology Therapeutic Area at Janssen Research & Development LLC.
He is on the Board of Directors at Bridgebio Oncology Therapeutics, Inc., Bridgebio Oncology Therapeutics, Inc. /New/ and Third Arc Bio, Inc. Dr. Lebowitz was previously employed as a Chief Executive Officer by Aragon Pharmaceuticals, Inc.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
-.--% | 20.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 2 |
|---|---|
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen